1. Home
  2. STXS vs MSD Comparison

STXS vs MSD Comparison

Compare STXS & MSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • MSD
  • Stock Information
  • Founded
  • STXS 1990
  • MSD 1993
  • Country
  • STXS United States
  • MSD United States
  • Employees
  • STXS N/A
  • MSD N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MSD Trusts Except Educational Religious and Charitable
  • Sector
  • STXS Health Care
  • MSD Finance
  • Exchange
  • STXS Nasdaq
  • MSD Nasdaq
  • Market Cap
  • STXS 173.5M
  • MSD 157.1M
  • IPO Year
  • STXS 2004
  • MSD N/A
  • Fundamental
  • Price
  • STXS $2.10
  • MSD $7.67
  • Analyst Decision
  • STXS Strong Buy
  • MSD
  • Analyst Count
  • STXS 2
  • MSD 0
  • Target Price
  • STXS $4.50
  • MSD N/A
  • AVG Volume (30 Days)
  • STXS 332.6K
  • MSD 70.2K
  • Earning Date
  • STXS 11-11-2024
  • MSD 01-01-0001
  • Dividend Yield
  • STXS N/A
  • MSD 11.26%
  • EPS Growth
  • STXS N/A
  • MSD N/A
  • EPS
  • STXS N/A
  • MSD N/A
  • Revenue
  • STXS $25,143,000.00
  • MSD N/A
  • Revenue This Year
  • STXS $1.16
  • MSD N/A
  • Revenue Next Year
  • STXS $55.65
  • MSD N/A
  • P/E Ratio
  • STXS N/A
  • MSD N/A
  • Revenue Growth
  • STXS N/A
  • MSD N/A
  • 52 Week Low
  • STXS $1.51
  • MSD $6.11
  • 52 Week High
  • STXS $3.29
  • MSD $7.46
  • Technical
  • Relative Strength Index (RSI)
  • STXS 53.19
  • MSD 49.09
  • Support Level
  • STXS $1.96
  • MSD $7.52
  • Resistance Level
  • STXS $2.12
  • MSD $7.65
  • Average True Range (ATR)
  • STXS 0.12
  • MSD 0.10
  • MACD
  • STXS 0.01
  • MSD 0.00
  • Stochastic Oscillator
  • STXS 50.00
  • MSD 49.50

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.

About MSD Morgan Stanley Emerging Markets Debt Fund Inc.

Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.

Share on Social Networks: